CF
KNSA icon

Corebridge Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Corebridge Financial’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,979
Closed -$355K – 1451
2025
Q1 		$355K Buy
15,979
+549
+4% +$11.3K ﹤0.01% 1767
2024
Q4 		$305K Sell
15,430
-819
-5% -$18.7K ﹤0.01% 1935
2024
Q3 		$406K Sell
16,249
-123
-0.8% -$3K ﹤0.01% 1838
2024
Q2 		$306K Buy
+16,372
New +$307K ﹤0.01% 1957

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return